Multi Dose Vials News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Multi Dose Vials. Real-time updates on events, politics, business and more.

Takeda, Biological E tie up for dengue vaccine

February 27, 2024

MDVs offer economic and logistical advantages for National Immunisation Programmes by minimising packaging and storage expenses, while also reducing medical and environmental waste.

Andhra Pradesh Mahima Datla Biologika Gmb Gary Dubin National Immunisation Programmes Global Vaccine Business Unit

Source: indianexpress.com

Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials

January 10, 2023

/PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce it has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL)...

Vijay Raghavan States Glenmark Prnewswire Glenmark Pharmaceuticals Inc Linkedin Glenmark Pharmaceuticals Tm National Sales Perspectives Business Development Portfolio

Source: prnewswire.com

Glenmark Pharmaceuticals launches Bumetanide Injection

January 10, 2023

Glenmark Pharmaceuticals Inc., USA has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials, the generic version of Bumex® Injection.

Vijay Raghavan States Glenmark Business Development Portfolio Validus Pharmaceuticals Glenmark Pharmaceuticals Glenmark Pharmaceuticals Inc

Source: equitybulls.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Multi Dose Vials News Today

Takeda, Biological E tie up for dengue vaccine

Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials

Glenmark Pharmaceuticals launches Bumetanide Injection

Explore More Categories